The University of Chicago Header Logo

Samuel Hellman

Concepts (303)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
26
2015
2903
1.440
Why?
Neoplasms
21
2023
2898
1.320
Why?
Neoplasm Metastasis
19
2016
1056
1.130
Why?
Prostatic Neoplasms
9
2007
1721
0.710
Why?
Radiotherapy
6
2014
328
0.710
Why?
Epigenesis, Genetic
1
2023
481
0.690
Why?
Antineoplastic Agents
8
2015
2360
0.510
Why?
Knowledge
1
2014
29
0.490
Why?
Neovascularization, Pathologic
6
2004
353
0.480
Why?
Education, Medical
2
2014
234
0.480
Why?
Models, Theoretical
3
2005
482
0.450
Why?
Physicians, Primary Care
1
2014
104
0.440
Why?
Randomized Controlled Trials as Topic
5
2004
865
0.420
Why?
Humans
72
2023
86678
0.420
Why?
Lymphatic Metastasis
8
2003
486
0.420
Why?
Physician-Patient Relations
4
2007
610
0.400
Why?
Radiation, Ionizing
4
2010
121
0.380
Why?
Radiation Oncology
3
1997
119
0.370
Why?
Human Experimentation
1
2010
39
0.350
Why?
Nucleoside-Diphosphate Kinase
2
2000
11
0.350
Why?
Ethics, Research
1
2010
52
0.350
Why?
Monomeric GTP-Binding Proteins
2
2000
18
0.340
Why?
Disease-Free Survival
12
2011
1204
0.340
Why?
Patient Advocacy
3
2015
49
0.330
Why?
MicroRNAs
4
2015
534
0.330
Why?
Chemotherapy, Adjuvant
8
2005
468
0.310
Why?
Genetic Therapy
9
2008
342
0.310
Why?
Physician's Role
4
2005
179
0.310
Why?
Models, Economic
1
2007
60
0.300
Why?
Hematopoiesis
1
2008
163
0.300
Why?
Neoplasm Recurrence, Local
5
2005
1313
0.290
Why?
Neoplastic Stem Cells
1
2008
143
0.280
Why?
Liver Neoplasms
3
2018
738
0.280
Why?
Decision Making
3
2007
642
0.280
Why?
Tumor Necrosis Factor-alpha
7
2008
683
0.280
Why?
Prostatectomy
3
2007
471
0.270
Why?
Hematopoietic Stem Cells
1
2008
292
0.270
Why?
Androgen Antagonists
2
2005
144
0.270
Why?
Prognosis
11
2005
3680
0.270
Why?
Attitude of Health Personnel
2
2005
636
0.270
Why?
Transcription Factors
6
2004
1565
0.270
Why?
Antineoplastic Agents, Hormonal
2
2003
150
0.250
Why?
Colorectal Neoplasms
3
2018
938
0.250
Why?
Ethics, Medical
3
2000
306
0.250
Why?
Prostate-Specific Antigen
2
1998
353
0.250
Why?
Attitude to Health
1
2005
220
0.240
Why?
Nitriles
1
2004
149
0.230
Why?
Triazoles
1
2004
96
0.230
Why?
Biomedical Research
3
2014
376
0.230
Why?
Epithelial-Mesenchymal Transition
1
2023
70
0.230
Why?
History, 20th Century
3
2010
312
0.220
Why?
Sentinel Lymph Node Biopsy
1
2003
68
0.220
Why?
Managed Care Programs
2
2000
42
0.210
Why?
Brachytherapy
1
2003
119
0.210
Why?
Melanoma
2
2013
459
0.200
Why?
Disease Progression
8
2012
1532
0.200
Why?
Proliferating Cell Nuclear Antigen
2
2000
66
0.200
Why?
Lymph Nodes
4
2000
533
0.200
Why?
Lymph Node Excision
1
2003
217
0.200
Why?
Aged
16
2018
18423
0.200
Why?
Biomarkers, Tumor
3
2003
1464
0.190
Why?
Medical Oncology
2
2014
359
0.190
Why?
Female
31
2018
44550
0.190
Why?
Carcinoma
1
2003
436
0.180
Why?
Survival Analysis
6
2013
1538
0.180
Why?
Combined Modality Therapy
9
2005
1686
0.180
Why?
Skin Neoplasms
1
2004
546
0.170
Why?
Clinical Trials as Topic
4
2014
1169
0.170
Why?
Middle Aged
16
2018
25040
0.170
Why?
Cadherins
1
2000
151
0.170
Why?
Radiosurgery
2
2013
272
0.170
Why?
Mammography
2
2000
463
0.160
Why?
Radiotherapy, Adjuvant
4
2005
292
0.160
Why?
Gene Amplification
1
2018
131
0.160
Why?
History, 21st Century
2
2009
175
0.140
Why?
Immediate-Early Proteins
4
2004
164
0.140
Why?
Mastectomy
2
2004
243
0.140
Why?
Quality of Health Care
1
2000
381
0.140
Why?
Antigens, Neoplasm
1
1998
325
0.140
Why?
Disease Models, Animal
4
2016
2231
0.130
Why?
Prescription Fees
1
2015
10
0.130
Why?
Consumer Advocacy
1
1995
10
0.130
Why?
Insurance Coverage
1
1996
117
0.130
Why?
Aged, 80 and over
7
2018
6513
0.130
Why?
Health Care Rationing
1
1996
83
0.130
Why?
Microcirculation
3
2000
106
0.130
Why?
United States
7
2015
6681
0.130
Why?
Chromosomes, Human, Pair 14
1
2015
49
0.130
Why?
Drug Costs
1
2015
62
0.130
Why?
Erectile Dysfunction
2
2007
74
0.120
Why?
Neoplasm Staging
5
2004
1939
0.120
Why?
Patients
1
1995
100
0.120
Why?
Medical Laboratory Science
1
1994
7
0.120
Why?
Radiotherapy, Computer-Assisted
2
2008
25
0.120
Why?
Clinical Medicine
1
1994
34
0.120
Why?
Aging
1
1998
691
0.120
Why?
Life Expectancy
1
1994
86
0.120
Why?
Genetic Engineering
1
1994
114
0.110
Why?
Patient Participation
1
2015
216
0.110
Why?
Urinary Incontinence
2
2007
206
0.110
Why?
Male
13
2018
40988
0.110
Why?
Adult
12
2018
25659
0.110
Why?
History, 19th Century
2
2009
59
0.110
Why?
Health Care Reform
1
1994
90
0.110
Why?
Data Interpretation, Statistical
2
2004
297
0.100
Why?
Treatment Outcome
6
2013
7998
0.100
Why?
Diagnostic Imaging
1
2015
469
0.100
Why?
Evidence-Based Medicine
2
2005
429
0.100
Why?
Animals
15
2016
26590
0.100
Why?
Informed Consent
2
2010
266
0.090
Why?
Neoplasm Transplantation
6
2016
391
0.090
Why?
Age Factors
3
2007
1852
0.090
Why?
Philosophy, Medical
2
2005
17
0.090
Why?
Follow-Up Studies
4
2000
3642
0.090
Why?
Multivariate Analysis
3
1998
1001
0.090
Why?
Ohio
1
2010
37
0.090
Why?
Tamoxifen
2
2004
168
0.090
Why?
Hodgkin Disease
1
1991
177
0.090
Why?
Biological Evolution
1
1997
919
0.090
Why?
NM23 Nucleoside Diphosphate Kinases
2
2000
5
0.090
Why?
Lung
2
2012
1169
0.090
Why?
Research Subjects
1
2010
73
0.090
Why?
X-Ray Therapy
1
2008
6
0.080
Why?
Universities
1
2010
135
0.080
Why?
Cell Line, Tumor
5
2015
2426
0.080
Why?
Lung Neoplasms
3
2013
2262
0.080
Why?
Analysis of Variance
2
2004
912
0.080
Why?
Military Personnel
1
2010
85
0.080
Why?
Survival Rate
3
2012
1864
0.080
Why?
Radiation-Sensitizing Agents
1
2008
95
0.080
Why?
Adenocarcinoma
3
2012
1169
0.080
Why?
Melanoma, Experimental
1
2008
103
0.080
Why?
Radiotherapy, Conformal
1
2008
83
0.080
Why?
Philosophy
1
2007
9
0.080
Why?
Urethral Stricture
1
2007
13
0.080
Why?
Rectal Diseases
1
2007
24
0.080
Why?
Practice Patterns, Physicians'
1
1993
584
0.080
Why?
Critical Pathways
1
2007
35
0.080
Why?
DNA-Binding Proteins
4
2004
1208
0.080
Why?
Mutation
1
2018
3968
0.070
Why?
Actuarial Analysis
2
1997
66
0.070
Why?
Time Factors
4
2005
5214
0.070
Why?
Phenotype
3
2015
2380
0.070
Why?
Fund Raising
1
2005
2
0.070
Why?
Academies and Institutes
1
2006
31
0.070
Why?
Predictive Value of Tests
3
2003
1673
0.070
Why?
Dermatology
1
2006
35
0.070
Why?
Gene Expression Regulation
3
2002
1921
0.070
Why?
Immunohistochemistry
3
2000
1753
0.070
Why?
Gene Expression Profiling
3
2018
1384
0.070
Why?
Trastuzumab
1
2005
68
0.060
Why?
Heterografts
2
2015
98
0.060
Why?
Sample Size
1
2005
130
0.060
Why?
Mastectomy, Radical
2
1995
10
0.060
Why?
Drug Administration Schedule
2
2003
916
0.060
Why?
Patient Satisfaction
1
2007
455
0.060
Why?
Antibiotics, Antineoplastic
1
2004
114
0.060
Why?
Databases, Factual
1
2007
816
0.060
Why?
Radiation Dosage
2
2011
227
0.060
Why?
Doxorubicin
1
2004
295
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2004
2438
0.060
Why?
Carcinoma, Lewis Lung
2
2000
23
0.050
Why?
Cell Transformation, Neoplastic
1
2005
427
0.050
Why?
Neoplasm Invasiveness
1
2004
552
0.050
Why?
Mice
9
2015
11356
0.050
Why?
Interdisciplinary Communication
1
2003
130
0.050
Why?
Surgical Procedures, Operative
1
2004
182
0.050
Why?
Early Growth Response Protein 1
4
2004
54
0.050
Why?
Kaplan-Meier Estimate
2
2018
861
0.050
Why?
Lymphedema
1
2003
77
0.050
Why?
Transcriptional Activation
1
2002
280
0.050
Why?
Sensitivity and Specificity
2
2003
1992
0.050
Why?
Risk
1
2003
674
0.050
Why?
Coumarins
1
2000
13
0.050
Why?
Dose-Response Relationship, Radiation
2
2000
188
0.050
Why?
Oligonucleotide Array Sequence Analysis
1
2003
689
0.050
Why?
Immunity, Cellular
1
2001
177
0.050
Why?
Risk Assessment
2
2005
2264
0.050
Why?
Tumor Cells, Cultured
5
2002
1041
0.050
Why?
Gene Expression
2
2015
1284
0.050
Why?
Cisplatin
1
2002
612
0.050
Why?
Databases as Topic
1
2000
92
0.040
Why?
Mice, Nude
5
2002
790
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2005
930
0.040
Why?
Cancer Vaccines
1
2001
156
0.040
Why?
Carcinoma, Lobular
1
2000
81
0.040
Why?
Antibodies, Monoclonal
1
2005
1376
0.040
Why?
Apoptosis
3
2008
1683
0.040
Why?
Plasminogen
1
1998
41
0.040
Why?
Genetic Vectors
4
2004
439
0.040
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
8
0.040
Why?
Carcinoma, Ductal, Breast
1
2000
157
0.040
Why?
Research
2
2003
253
0.040
Why?
Receptor, Notch1
1
2018
85
0.040
Why?
Transcription, Genetic
1
2002
1135
0.040
Why?
Paraffin Embedding
1
1997
78
0.040
Why?
Severity of Illness Index
1
2003
1802
0.040
Why?
Xenograft Model Antitumor Assays
2
2011
458
0.040
Why?
Mutagenesis
1
1997
199
0.040
Why?
Adrenalectomy
1
1996
43
0.040
Why?
Axilla
1
1997
99
0.040
Why?
Neoplasm Proteins
1
2000
532
0.040
Why?
Insurance, Health
1
1998
160
0.040
Why?
Peptide Fragments
1
1998
460
0.040
Why?
Ovariectomy
1
1996
81
0.040
Why?
HCT116 Cells
1
2016
151
0.040
Why?
Researcher-Subject Relations
1
1996
4
0.030
Why?
Vascular Endothelial Growth Factor A
1
2018
407
0.030
Why?
Molecular Biology
1
1996
89
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2004
1075
0.030
Why?
Immunotherapy
1
2001
629
0.030
Why?
Social Responsibility
1
1996
57
0.030
Why?
Fibrosarcoma
1
1995
84
0.030
Why?
Luminescent Measurements
1
2015
57
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
1996
176
0.030
Why?
DNA Repair
1
1997
356
0.030
Why?
Cell Nucleus
1
1997
580
0.030
Why?
Laryngeal Neoplasms
1
1995
89
0.030
Why?
Algorithms
1
2003
1830
0.030
Why?
Mice, Inbred NOD
1
2015
187
0.030
Why?
Likelihood Functions
1
1995
251
0.030
Why?
Mice, SCID
1
2015
252
0.030
Why?
Proportional Hazards Models
1
1996
860
0.030
Why?
Research Design
2
2003
594
0.030
Why?
Tumor Burden
1
2015
289
0.030
Why?
Neoplasms, Experimental
1
1995
269
0.030
Why?
Social Values
1
1994
44
0.030
Why?
Socioeconomic Factors
1
1996
567
0.030
Why?
Regression Analysis
1
1995
596
0.030
Why?
Diffusion of Innovation
1
1994
71
0.030
Why?
Receptors, Estrogen
1
1995
384
0.030
Why?
Genetic Diseases, Inborn
1
1994
101
0.030
Why?
Health Care Costs
1
1995
239
0.030
Why?
Patient-Centered Care
1
1995
203
0.030
Why?
Imaging, Three-Dimensional
1
2016
579
0.030
Why?
Forecasting
1
1994
305
0.030
Why?
Molecular Targeted Therapy
1
2014
266
0.030
Why?
Adenoviridae
2
2004
345
0.030
Why?
Social Change
1
1991
7
0.030
Why?
England
1
1991
41
0.020
Why?
Acquired Immunodeficiency Syndrome
1
1991
78
0.020
Why?
Maximum Tolerated Dose
1
2011
270
0.020
Why?
Cluster Analysis
1
2011
369
0.020
Why?
Costs and Cost Analysis
1
1991
153
0.020
Why?
Databases, Genetic
1
2011
260
0.020
Why?
Precision Medicine
1
2014
395
0.020
Why?
Promoter Regions, Genetic
2
2004
937
0.020
Why?
Carcinoma, Squamous Cell
1
1996
1077
0.020
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2008
20
0.020
Why?
Etanercept
1
2008
32
0.020
Why?
Esophageal Neoplasms
2
2002
322
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2008
43
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2008
88
0.020
Why?
Health Knowledge, Attitudes, Practice
1
1993
508
0.020
Why?
Rats
2
2004
3992
0.020
Why?
Double-Blind Method
1
1991
1824
0.020
Why?
Immunoglobulin G
1
2008
456
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2011
1197
0.020
Why?
Delivery of Health Care
1
1991
426
0.020
Why?
Retrospective Studies
1
2000
8496
0.020
Why?
Endothelial Cells
1
2008
429
0.020
Why?
Necrosis
2
1996
204
0.020
Why?
Reproducibility of Results
1
2011
2706
0.020
Why?
Pleural Effusion
1
2004
45
0.020
Why?
Organoplatinum Compounds
1
2004
94
0.020
Why?
Acetylcysteine
1
2004
69
0.020
Why?
Recombinant Fusion Proteins
2
1996
557
0.020
Why?
Biopsy, Needle
1
2004
235
0.010
Why?
Immunosuppressive Agents
1
2008
977
0.010
Why?
Genes, erbB-2
1
2003
24
0.010
Why?
Probability
1
2004
355
0.010
Why?
Selective Estrogen Receptor Modulators
1
2003
34
0.010
Why?
Mice, Inbred C57BL
2
2000
3095
0.010
Why?
Receptors, Steroid
1
2003
42
0.010
Why?
Paclitaxel
1
2004
460
0.010
Why?
DNA, Complementary
1
2002
393
0.010
Why?
Phytotherapy
1
2003
133
0.010
Why?
Up-Regulation
1
2004
715
0.010
Why?
Isocoumarins
1
2000
7
0.010
Why?
Umbilical Veins
1
2000
46
0.010
Why?
Drug Resistance, Neoplasm
1
2004
592
0.010
Why?
Laminin
1
2000
85
0.010
Why?
ROC Curve
1
2003
752
0.010
Why?
Drug Combinations
1
2000
224
0.010
Why?
Proteoglycans
1
2000
121
0.010
Why?
Mass Screening
1
2004
619
0.010
Why?
Collagen
1
2000
269
0.010
Why?
Angiostatins
1
1998
15
0.010
Why?
Cytokines
1
2003
778
0.010
Why?
Endothelium, Vascular
1
2000
435
0.010
Why?
Colonic Neoplasms
1
2002
558
0.010
Why?
Cohort Studies
1
2004
2768
0.010
Why?
Cell Movement
1
2000
758
0.010
Why?
Biomarkers
1
2003
1718
0.010
Why?
Dose-Response Relationship, Drug
1
2000
1961
0.010
Why?
Mastadenovirus
1
1995
4
0.010
Why?
Liposomes
1
1995
91
0.010
Why?
Cells, Cultured
1
2000
2819
0.010
Why?
Neoplasms, Radiation-Induced
1
1995
109
0.010
Why?
Radiation Tolerance
1
1995
168
0.010
Why?
Transplantation, Heterologous
1
1995
363
0.010
Why?
Thrombosis
1
1996
296
0.010
Why?
Signal Transduction
1
2003
3243
0.010
Why?
Hellman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (303)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_